title: Synthesis and immunochemical characterization of protein conjugates of carbohydrate and carbohydrate-mimetic peptides as experimental vaccines.
abstract: The peptides DRPVPY and MDWNMHAA, which were identified as mimics of the cell-surface polysaccharides of Streptococcus Group A and Shigella flexneri Y, respectively, were used in this study to develop experimental vaccines directed against these two bacteria. Both oligopeptides were synthesized employing the Fmoc solid-phase strategy and linked via the amino end to a bifunctional linker, diethylsquarate. These adducts were then conjugated to the two carrier proteins, bovine serum albumin (BSA) and tetanus toxoid (TT) to yield the peptide conjugate vaccines. The average level of incorporation of DRPVPY and MDWNMHAA on TT was 65% and 75%, respectively, whereas that of both peptide haptens on BSA was 100%. A polysaccharide conjugate against S. flexneri Y, which comprises about 10 tetrasaccharide repeating units, was also prepared based on reductive amination at the reducing end with 1,3-diaminopropane, followed by coupling of the aminated polysaccharide to diethylsquarate, and subsequent coupling of the adduct to TT. An average incorporation of 73% of polysaccharide haptens was achieved. The glycoconjugate and the oligopeptide conjugates were shown to bind effectively to the respective monoclonal antibodies directed against the cell-surface polysaccharides.
authors.affiliation: Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada V5A 1S6.
authors.forename: Rehana B
authors.initials: RB
authors.lastname: Hossany
authors.forename: Margaret A
authors.initials: MA
authors.lastname: Johnson
authors.forename: Adewale A
authors.initials: AA
authors.lastname: Eniade
authors.forename: B Mario
authors.initials: BM
authors.lastname: Pinto
mesh_terms: D000595:Amino Acid Sequence; D000906:Antibodies / Q000276:immunology; D000941:Antigens / Q000276:immunology; D040761:Biomimetic Materials / Q000138:chemical synthesis* / Q000737:chemistry; D002240:Carbohydrate Sequence; D002241:Carbohydrates / Q000737:chemistry* / Q000276:immunology*; D006001:Glycoconjugates / Q000737:chemistry / Q000276:immunology; D020128:Inhibitory Concentration 50; D008070:Lipopolysaccharides / Q000276:immunology; D010455:Peptides / Q000138:chemical synthesis / Q000737:chemistry* / Q000276:immunology*; D011506:Proteins / Q000737:chemistry / Q000276:immunology; D012763:Shigella flexneri / Q000737:chemistry / Q000276:immunology; D013297:Streptococcus pyogenes / Q000737:chemistry / Q000276:immunology; D014612:Vaccines / Q000138:chemical synthesis / Q000737:chemistry* / Q000276:immunology*
chemical_list: D000906:Antibodies; D000941:Antigens; D002241:Carbohydrates; D006001:Glycoconjugates; D008070:Lipopolysaccharides; D010455:Peptides; D011506:Proteins; D014612:Vaccines